Advanced Stage NSCLC
This frontal view x-ray of the chest shows advanced stage non-small cell lung cancer (NSCLC) of a 50-year-old woman with a long history of smoking and emphysema. The orange area depicts collapsed lung tissue at the base of the right lung, and the yellow area highlights a pleura-based density along the right hemithorax.
Fluorodeoxyglucose FDG-PET Scan
Fluorodeoxyglucose positron emission tomography (FDG-PET) scan of the chest (axial section) shows cancer in the right lung. The rapidly growing, highly metabolic cancer cells of the tumor take up the FDG, causing a distinguished appearance from the other lung tissue cells/benign tumors. FDG is useful in diagnosing, staging, and following tumors.
CT scan of the axial section of the thorax highlighting bronchopulmonary small cell lung cancer (SCLC) with a large middle mediastinum mass.
PET/CT Fusion Imaging
The PET/CT fusion image shows non-small cell lung cancer (NSCLC) of the right lung, with an early stage of another type of cancer showing up in the yellow/pink highlighted area. PET/CT fusion imaging is a multimodality technology that allows the correlation of findings from two concurrent imaging modalities.
3D CT Scan Model
Posterior view of a 3D CT scan model showing advanced non-small cell lung cancer (NSCLC) in a patient who had a long history of smoking and emphysema. The large pleura-based mass (green) has eroded through the ribs and thoracic vertebrae.
MRI Scan Showing SCLC
MRI scan of the abdomen highlighting small cell lung cancer (SCLC).
Lung Tumor Invading an Alveolus
Electron microscope using a colored scan to highlight a lung tumor (red) invading an alveolus. The cancer cells are covered with microvilli.
Masses in Both Lungs
Color coded chest x-ray showing masses (orange silhouettes) in both lungs.
Small Cell Lung Cancer
Colored coded chest x-ray highlighting small cell lung cancer (SCLC) represented in orange.
More people in the United States die from lung cancer than any other type of cancer. This is true for both men and women. According to the most currently available epidemiologic data from the US Centers for Disease Control and Prevention, 208,493 people were diagnosed with lung cancer in 2008, including 111,886 men and 96,607 women; among those, there were a total of 158,592 deaths from lung cancer. A recent report from the American Cancer Society estimates that there will be a total of 226,160 newly diagnosed cases of lung cancer in the US in 2012; of these, 160,340 will die of the disease.
- Herbal Remedies May Be an Overlooked Global Health Hazard
- New Research Questions Recommendations Regarding PSA Tests for Prostate Cancer Screening
- Specific Lifestyle Factors Can Significantly Affect Cancer Mortality
- Adhering to Patient Preferences Improves Patient Comfort During Skin Cancer Screening
- Atezolizumab Approved for Locally Advanced or Metastatic Urothelial Carcinoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Initiating Palliative Care in the Emergency Department
- Implementing a Distress Screening Process for Cancer Patients
- Cancer-related Neuropathy May Respond to Gene Therapy
- Socioeconomic Benefits of Marriage Improve Survival Among Married Patients
- Vitamin D and Androgen Receptor-Targeted Therapy Are Effective in Triple-Negative Breast Cancer
- Consensus Statement Guides Optimal Management of EGFR-Mutation-Positive NSCLC
- Including Proteomics Is Key to Achieving Goals of National Cancer Moonshot
- Violence in Health Care Workplaces: "Underreported, Tolerated, and Largely Ignored"
- Vessel-Sparing Radiation Successfully Treats Prostate Cancer, Maintains Quality of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|